Detalhe da pesquisa
1.
Sex differences in carcinoid syndrome: A gap to be closed.
Rev Endocr Metab Disord
; 23(3): 659-669, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35292889
2.
Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms.
Expert Rev Endocrinol Metab
; 19(1): 49-61, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936421
3.
Recent advances and future challenges in the diagnosis of neuroendocrine neoplasms.
Minerva Endocrinol (Torino)
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38625065
4.
Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune-Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC).
J Pers Med
; 13(6)2023 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37373942
5.
Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1.
Metabolites
; 13(2)2023 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36837874
6.
Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives.
Expert Rev Endocrinol Metab
; 17(5): 389-403, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35822906
7.
Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target.
Metabolites
; 12(11)2022 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355141
8.
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.
Front Endocrinol (Lausanne)
; 12: 649496, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33815296
9.
Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications.
Front Endocrinol (Lausanne)
; 12: 665631, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33935975